Kairos Consulting Services works with biotech and pharma firms to optimise their BD strategy, non-dilutive fund sourcing including grants and tax incentives as well as biologic drug candidate/lead R&D, outsourcing, licensing, and service and product sales. Kairos specializes in virtual and early-stage companies with a focus on biologics (antibody) pre-clinical development including: antibody drug discovery, engineering, humanization, protein expression and cell line development. Kairos also assists CRO’s with BD and sales within Canada and North America with a focus in the Pacific Northwest and the North American West Coast. We have international experience with projects completed in Canada, USA, Middle East and the UK. Our services have helped both academic institutions as well as private and public biotech and we experience with projects that bridge academia with biotech and the pharma industry.